gadolinium nephrogenic systemic fibrosis
A total of 779 NSF reports received by Bayer globally from 2006 to 2016 were included in the analysis. Arlington Medical Resources provided gadolinium-based ... ,Kidney Int. 2007 Aug;72(3):260-4. Epub 2007 May 16. Gadolinium and nephrogenic systemic fibrosis. Grobner T(1), Prischl FC. Author information: (1)12nd ... ,Pediatr Nephrol. 2014 Oct;29(10):1927-37. doi: 10.1007/s00467-013-2636-z. Epub 2013 Oct 22. Gadolinium and nephrogenic systemic fibrosis: an update. ,Nephrogenic systemic fibrosis (NSF) is a clinicopathologic syndrome that has been associated with the use of gadolinium-based contrast agents (GBCAs).1 First ... ,Semin Nephrol. 2011 May;31(3):310-6. doi: 10.1016/j.semnephrol.2011.05.010. Gadolinium-induced nephrogenic systemic fibrosis. Hellman RN(1). ,Background. In 2006, nephrologists in Denmark unexpectedly identified chronic kidney disease (CKD) patients with a new syndrome, nephrogenic systemic ... , Nephrogenic systemic fibrosis can begin days to months after exposure to gadolinium-containing contrast, but progresses quickly. Some signs ...,the exposure to Gadolinium (Gd)-based magnetic resonance image contrast agents, and ... Key Words：Gadolinium, Nephrogenic systemic fibrosis, Renal failure. , 簡介NSF是一種只在慢性腎衰竭病患出現的疾病，其有兩大特徵，分別為四肢 ... 在限制腎衰竭患者使用Gadolinium顯影劑後，新產生患者的數量快速 ...
| 相關軟體 mIRC 資訊 | |
|---|---|
 gadolinium nephrogenic systemic fibrosis 相關參考資料
10 Years of Nephrogenic Systemic Fibrosis - NCBI - NIH
A total of 779 NSF reports received by Bayer globally from 2006 to 2016 were included in the analysis. Arlington Medical Resources provided gadolinium-based ... https://www.ncbi.nlm.nih.gov Gadolinium and nephrogenic systemic fibrosis. - NCBI
Kidney Int. 2007 Aug;72(3):260-4. Epub 2007 May 16. Gadolinium and nephrogenic systemic fibrosis. Grobner T(1), Prischl FC. Author information: (1)12nd ... https://www.ncbi.nlm.nih.gov Gadolinium and nephrogenic systemic fibrosis: an update. - NCBI
Pediatr Nephrol. 2014 Oct;29(10):1927-37. doi: 10.1007/s00467-013-2636-z. Epub 2013 Oct 22. Gadolinium and nephrogenic systemic fibrosis: an update. https://www.ncbi.nlm.nih.gov Gadolinium-Induced Nephrogenic Systemic Fibrosis - NCBI - NIH
Nephrogenic systemic fibrosis (NSF) is a clinicopathologic syndrome that has been associated with the use of gadolinium-based contrast agents (GBCAs).1 First ... https://www.ncbi.nlm.nih.gov Gadolinium-induced nephrogenic systemic fibrosis. - NCBI
Semin Nephrol. 2011 May;31(3):310-6. doi: 10.1016/j.semnephrol.2011.05.010. Gadolinium-induced nephrogenic systemic fibrosis. Hellman RN(1). https://www.ncbi.nlm.nih.gov Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of ...
Background. In 2006, nephrologists in Denmark unexpectedly identified chronic kidney disease (CKD) patients with a new syndrome, nephrogenic systemic ... https://www.ncbi.nlm.nih.gov Nephrogenic systemic fibrosis - Symptoms and causes - Mayo Clinic
Nephrogenic systemic fibrosis can begin days to months after exposure to gadolinium-containing contrast, but progresses quickly. Some signs ... https://www.mayoclinic.org Nephrogenic Systemic Fibrosis - Taiwan Society of Internal Medicine
the exposure to Gadolinium (Gd)-based magnetic resonance image contrast agents, and ... Key Words：Gadolinium, Nephrogenic systemic fibrosis, Renal failure. http://www.tsim.org.tw 腎源性系統性纖維化(Nephrogenic systemic fibrosis) - Tiny Notes
簡介NSF是一種只在慢性腎衰竭病患出現的疾病，其有兩大特徵，分別為四肢 ... 在限制腎衰竭患者使用Gadolinium顯影劑後，新產生患者的數量快速 ... https://thetinynotes.com |